Vivos (RDGL) Net Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) Net Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vivos | - | - | -3,105.00 | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -57,410.00 |
| Mar 31, 2025 | 929,139.00 |
| Sep 30, 2024 | -696,683.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -827,334.00 |
| Sep 30, 2023 | -527,589.00 |
| Jun 30, 2023 | -638,465.00 |
| Mar 31, 2023 | 124,525.00 |
| Sep 30, 2022 | -291,129.00 |
| Sep 30, 2021 | 58,577.00 |
| Sep 30, 2020 | 643,014.00 |
| Mar 31, 2018 | 515,505.00 |
| Mar 31, 2017 | 13.29 Mn |
| Sep 30, 2016 | 1.71 Mn |
| Mar 31, 2016 | -15.63 Mn |
| Mar 31, 2015 | 2.08 Mn |
| Mar 31, 2014 | -526,766.00 |
| Sep 30, 2013 | 279,663.00 |